Want to join the conversation?
For $MYL's Generics segment, sales in Rest of World region were just under $550MM, a YoverY growth of 47% on constant currency basis. Legacy business sales grew 21% on constant currency basis, driven by new product launches in Australia and Japan and higher volumes from India operations, especially ARV franchise, and promising business in Brazil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?